DFCI

Boston, Massachusetts 02215-5450

2 studies enrolling now · 6 studies all time

What they study most

Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemias, Advanced Solid Tumor, Bladder Cancer, CMML, Cancer, Chronic Lymphocytic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML)

Studies at this site

• Study in Advanced Solid Tumor Patients — Recruiting now
• A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) — Recruiting now
• Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors — Completed
• Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma — Completed
• A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors — Completed
• Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma — Stopped early